Acknowledgements


We acknowledge the contribution of the Alpha network in bringing together researchers to analyse their data and write up their results. The Alpha network is funded by Wellcome Trust (grant 075886/Z/04/Z).

The TAZAMA HIV and demographic surveillance studies are supported by grants from the Global Fund for AIDS, TB and Malaria to the Tanzanian government, and the data management is supported by a Bio-Medical Resource grant from the Wellcome Trust (Zaba et al., 2012, Isingo et al., 2012, Wringe et al., 2012a, Wringe et al., 2012b, Marston et al., 2012, Floyd et al., 2012).

Funding for the Africa Centre’s Demographic Surveillance Information System and Population-based HIV Survey was received from the Wellcome Trust, UK (grant 082384/Z/07/Z). The Hlabisa HIV Treatment and Care Programme is supported by the US President’s Emergency Plan for AIDS. TB was supported by grant 1R01-HD058482-01 from the National Institute of Child Health and Human Development (Floyd et al., 2012, Barnighausen et al., 2012).

The General Population Cohort receives financial support from the Medical Research Council (UK) through its core funding for the MRC/UVRI Uganda Research Unit on AIDS (Wringe et al., 2012a, Kazooba et al., 2012, Kasamba et al., 2012, Floyd et al., 2012).

The Manicaland Study is funded by the Wellcome Trust UK (grant number 084401/Z/07/Z) (Wringe et al., 2012a).

The Karonga Prevention Study (KPS) is funded by the Wellcome Trust (grant number WT 079828/Z/06/Z) (Wringe et al., 2012a, Chihana et al., 2012, Floyd et al., 2012).

The Rakai Health Sciences Program is supported by BMGF (grant number 22006.03) and NIH/NICHD (grant number R01HD050180) funding (Makumbi et al., 2012).

The funders had no role in the design of the studies, data analysis, interpretation of results or writing of the manuscripts for any papers in this supplement.

Ancillary